Area of research
Immunology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, Gastric Cancer Management and Outcomes, and Immune cells in cancer.
Complement receptor <scp>C5aR1</scp> blockade reprograms tumor‐associated macrophages and synergizes with <scp>anti‐PD</scp>‐1 therapy in gastric cancer
Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer
Somatic ARID1A mutation stratifies patients with gastric cancer to PD-1 blockade and adjuvant chemotherapy
CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration
Intratumoral CXCR5+CD8+T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer
Impact of intratumoural CD73 expression on prognosis and therapeutic response in patients with gastric cancer
Clinical Outcomes and Immune Metrics in Intratumoral Basophil-Enriched Gastric Cancer Patients
Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer
Morbidity and Mortality of Laparoscopic vs Open Total Gastrectomy for Clinical Stage I Gastric Cancer
Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients
Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103+CD8+ T cells conferring favourable prognosis
<scp>Lymphocyte‐activation gene 3 expression associates with poor prognosis and immunoevasive contexture in Epstein‐Barr virus‐positive and MLH1‐defective gastric cancer patients</scp>
Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer
Intratumoral IL17-producing cells infiltration correlate with antitumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer
Tumor-infiltrating γδT cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer
CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer
<scp>K</scp>lotho suppresses tumor progression via inhibiting <scp>PI</scp>3<scp>K</scp>/<scp>A</scp>kt/<scp>GSK</scp>3β/Snail signaling in renal cell carcinoma
Klotho Endows Hepatoma Cells with Resistance to Anoikis via VEGFR2/PAK1 Activation in Hepatocellular Carcinoma
Sorafenib suppresses growth and survival of hepatoma cells by accelerating degradation of enhancer of zeste homolog 2
Hepatitis <scp>B</scp> virus <scp>X</scp> protein promotes hepatoma cell invasion and metastasis by stabilizing <scp>S</scp>nail protein
Snail is an independent prognostic predictor for progression and patient survival of gastric cancer